Climate change threatens the existence of numerous plant species in our world. Now, a team of innovative undergraduates from the University of Rochester has risen to the challenge.
Meet "Team RoSynth," a group of ten students who, with their cutting-edge 3D-bioprinting system, are revolutionizing the production of plant-based pharmaceuticals without relying on actual plants.
Imagine a scenario where essential medicinal plants vanish. Although it's not our reality, the rapid depletion of plant-derived drugs is a global concern. Many pharmaceuticals in the U.S. heavily depend on imported raw plant materials, making them vulnerable to climate conditions, invasive pests, and farming challenges.
Team RoSynth, however, decided to tackle this issue head-on. In their quest to efficiently replicate beneficial plant chemicals, especially those endangered by climate change, they developed an affordable 3D-printing system. This breakthrough can potentially transform the field of synthetic biology, making the production of engineered living materials more accessible.
To read more, click here.